Loading…
Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori
The present study has been undertaken to apply the concept of nanoparticulate mucopenetrating drug delivery system for complete eradication of Helicobacter pylori (H. pylori), colonised deep into the gastric mucosal lining. Most of the existing drug delivery systems have failed on account of either...
Saved in:
Published in: | Scientia pharmaceutica 2011-07, Vol.79 (3), p.673-694 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3375-b1518f04023f8f5e825a88fe2527ec67043dcc1a14d95f4a18038c313d6d3a5d3 |
---|---|
cites | |
container_end_page | 694 |
container_issue | 3 |
container_start_page | 673 |
container_title | Scientia pharmaceutica |
container_volume | 79 |
creator | Arora, Saahil Gupta, Sankalp Narang, Raj K Budhiraja, Ramji D |
description | The present study has been undertaken to apply the concept of nanoparticulate mucopenetrating drug delivery system for complete eradication of Helicobacter pylori (H. pylori), colonised deep into the gastric mucosal lining. Most of the existing drug delivery systems have failed on account of either improper mucoadhesion or mucopenetration and no dosage form with dual activity of adhesion and penetration has been designed till date for treating H. pylori induced disorders. In the present study, novel chitosan-alginate polyelectrolyte complex (CS-ALG PEC) nanoparticles of amoxicillin have been designed and optimized for various variables such as pH and mixing ratio of polymers, concentrations of polymers, drug and surfactant, using 3(3) Box-Behnken design. Various studies like particle size, surface charge, percent drug entrapment, in-vitro mucoadhesion and in-vivo mucopenetration of nanoparticles on rat models were conducted. The optimised FITC labelled CS-ALG PEC nanoparticles have shown comparative low in-vitro mucoadhesion with respect to plain chitosan nanoparticles, but excellent mucopenetration and localization as observed with increased fluorescence in gastric mucosa continuously over 6 hours, which clinically can help in eradication of H. pylori. |
doi_str_mv | 10.3797/scipharm.1011-05 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3163361</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2439647311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3375-b1518f04023f8f5e825a88fe2527ec67043dcc1a14d95f4a18038c313d6d3a5d3</originalsourceid><addsrcrecordid>eNpdkU1v3CAQhlHVqtlue--pQr305C1jjI0vlaKoX1Kk5JCeEYHxLhEGF-woVv98WeVDbU4M4uHVzDyEvAe2413ffc7GTQedxh0wgIqJF2RT1yBLxeuXZMMYbyvZsf6EvMn5hrEWGuhek5PCyLYH2JA_p2O8c8Z57wL1UVu01BzcHLMOlfZ7F_SMdIp-RY9mTqUodxPHyeMdDTrESafZGY-Z6kzHxcQJA85Jzy7sqUXvbjGtNK95xpEOMdHDjl6uPib3lrwatM_47uHckl_fvl6d_ajOL77_PDs9rwznnaiuQYAcWMNqPshBoKyFlnLAWtQdmrZjDbfGgIbG9mJoNEjGpeHAbWu5FpZvyZf73Gm5HtEaDKU9r6bkRp1WFbVT_78Ed1D7eKs4tJy3UAI-PQSk-HvBPKvRZYPe64Bxyaove27rYqSQH5-RN3FJoUynysaFaDkcIXYPmRRzTjg8tQJMHb2qR6_q6FUVm1vy4d8Rnj48iuR_AbwYpGk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>886556319</pqid></control><display><type>article</type><title>Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><source>Free Full-Text Journals in Chemistry</source><creator>Arora, Saahil ; Gupta, Sankalp ; Narang, Raj K ; Budhiraja, Ramji D</creator><creatorcontrib>Arora, Saahil ; Gupta, Sankalp ; Narang, Raj K ; Budhiraja, Ramji D</creatorcontrib><description>The present study has been undertaken to apply the concept of nanoparticulate mucopenetrating drug delivery system for complete eradication of Helicobacter pylori (H. pylori), colonised deep into the gastric mucosal lining. Most of the existing drug delivery systems have failed on account of either improper mucoadhesion or mucopenetration and no dosage form with dual activity of adhesion and penetration has been designed till date for treating H. pylori induced disorders. In the present study, novel chitosan-alginate polyelectrolyte complex (CS-ALG PEC) nanoparticles of amoxicillin have been designed and optimized for various variables such as pH and mixing ratio of polymers, concentrations of polymers, drug and surfactant, using 3(3) Box-Behnken design. Various studies like particle size, surface charge, percent drug entrapment, in-vitro mucoadhesion and in-vivo mucopenetration of nanoparticles on rat models were conducted. The optimised FITC labelled CS-ALG PEC nanoparticles have shown comparative low in-vitro mucoadhesion with respect to plain chitosan nanoparticles, but excellent mucopenetration and localization as observed with increased fluorescence in gastric mucosa continuously over 6 hours, which clinically can help in eradication of H. pylori.</description><identifier>ISSN: 0036-8709</identifier><identifier>EISSN: 2218-0532</identifier><identifier>DOI: 10.3797/scipharm.1011-05</identifier><identifier>PMID: 21886911</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><ispartof>Scientia pharmaceutica, 2011-07, Vol.79 (3), p.673-694</ispartof><rights>Copyright Österreichischer Apotheker-Verlagsgesellschaft m.b.H (Austrian Pharmacists' Publishing House) 2011</rights><rights>Arora ; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3375-b1518f04023f8f5e825a88fe2527ec67043dcc1a14d95f4a18038c313d6d3a5d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/886556319/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/886556319?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21886911$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arora, Saahil</creatorcontrib><creatorcontrib>Gupta, Sankalp</creatorcontrib><creatorcontrib>Narang, Raj K</creatorcontrib><creatorcontrib>Budhiraja, Ramji D</creatorcontrib><title>Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori</title><title>Scientia pharmaceutica</title><addtitle>Sci Pharm</addtitle><description>The present study has been undertaken to apply the concept of nanoparticulate mucopenetrating drug delivery system for complete eradication of Helicobacter pylori (H. pylori), colonised deep into the gastric mucosal lining. Most of the existing drug delivery systems have failed on account of either improper mucoadhesion or mucopenetration and no dosage form with dual activity of adhesion and penetration has been designed till date for treating H. pylori induced disorders. In the present study, novel chitosan-alginate polyelectrolyte complex (CS-ALG PEC) nanoparticles of amoxicillin have been designed and optimized for various variables such as pH and mixing ratio of polymers, concentrations of polymers, drug and surfactant, using 3(3) Box-Behnken design. Various studies like particle size, surface charge, percent drug entrapment, in-vitro mucoadhesion and in-vivo mucopenetration of nanoparticles on rat models were conducted. The optimised FITC labelled CS-ALG PEC nanoparticles have shown comparative low in-vitro mucoadhesion with respect to plain chitosan nanoparticles, but excellent mucopenetration and localization as observed with increased fluorescence in gastric mucosa continuously over 6 hours, which clinically can help in eradication of H. pylori.</description><issn>0036-8709</issn><issn>2218-0532</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkU1v3CAQhlHVqtlue--pQr305C1jjI0vlaKoX1Kk5JCeEYHxLhEGF-woVv98WeVDbU4M4uHVzDyEvAe2413ffc7GTQedxh0wgIqJF2RT1yBLxeuXZMMYbyvZsf6EvMn5hrEWGuhek5PCyLYH2JA_p2O8c8Z57wL1UVu01BzcHLMOlfZ7F_SMdIp-RY9mTqUodxPHyeMdDTrESafZGY-Z6kzHxcQJA85Jzy7sqUXvbjGtNK95xpEOMdHDjl6uPib3lrwatM_47uHckl_fvl6d_ajOL77_PDs9rwznnaiuQYAcWMNqPshBoKyFlnLAWtQdmrZjDbfGgIbG9mJoNEjGpeHAbWu5FpZvyZf73Gm5HtEaDKU9r6bkRp1WFbVT_78Ed1D7eKs4tJy3UAI-PQSk-HvBPKvRZYPe64Bxyaove27rYqSQH5-RN3FJoUynysaFaDkcIXYPmRRzTjg8tQJMHb2qR6_q6FUVm1vy4d8Rnj48iuR_AbwYpGk</recordid><startdate>201107</startdate><enddate>201107</enddate><creator>Arora, Saahil</creator><creator>Gupta, Sankalp</creator><creator>Narang, Raj K</creator><creator>Budhiraja, Ramji D</creator><general>MDPI AG</general><general>Österreichische Apotheker-Verlagsgesellschaft</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BFMQW</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201107</creationdate><title>Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori</title><author>Arora, Saahil ; Gupta, Sankalp ; Narang, Raj K ; Budhiraja, Ramji D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3375-b1518f04023f8f5e825a88fe2527ec67043dcc1a14d95f4a18038c313d6d3a5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arora, Saahil</creatorcontrib><creatorcontrib>Gupta, Sankalp</creatorcontrib><creatorcontrib>Narang, Raj K</creatorcontrib><creatorcontrib>Budhiraja, Ramji D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Continental Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientia pharmaceutica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arora, Saahil</au><au>Gupta, Sankalp</au><au>Narang, Raj K</au><au>Budhiraja, Ramji D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori</atitle><jtitle>Scientia pharmaceutica</jtitle><addtitle>Sci Pharm</addtitle><date>2011-07</date><risdate>2011</risdate><volume>79</volume><issue>3</issue><spage>673</spage><epage>694</epage><pages>673-694</pages><issn>0036-8709</issn><eissn>2218-0532</eissn><abstract>The present study has been undertaken to apply the concept of nanoparticulate mucopenetrating drug delivery system for complete eradication of Helicobacter pylori (H. pylori), colonised deep into the gastric mucosal lining. Most of the existing drug delivery systems have failed on account of either improper mucoadhesion or mucopenetration and no dosage form with dual activity of adhesion and penetration has been designed till date for treating H. pylori induced disorders. In the present study, novel chitosan-alginate polyelectrolyte complex (CS-ALG PEC) nanoparticles of amoxicillin have been designed and optimized for various variables such as pH and mixing ratio of polymers, concentrations of polymers, drug and surfactant, using 3(3) Box-Behnken design. Various studies like particle size, surface charge, percent drug entrapment, in-vitro mucoadhesion and in-vivo mucopenetration of nanoparticles on rat models were conducted. The optimised FITC labelled CS-ALG PEC nanoparticles have shown comparative low in-vitro mucoadhesion with respect to plain chitosan nanoparticles, but excellent mucopenetration and localization as observed with increased fluorescence in gastric mucosa continuously over 6 hours, which clinically can help in eradication of H. pylori.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>21886911</pmid><doi>10.3797/scipharm.1011-05</doi><tpages>22</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0036-8709 |
ispartof | Scientia pharmaceutica, 2011-07, Vol.79 (3), p.673-694 |
issn | 0036-8709 2218-0532 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3163361 |
source | PubMed (Medline); Publicly Available Content Database; Free Full-Text Journals in Chemistry |
title | Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A52%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amoxicillin%20loaded%20chitosan-alginate%20polyelectrolyte%20complex%20nanoparticles%20as%20mucopenetrating%20delivery%20system%20for%20h.%20Pylori&rft.jtitle=Scientia%20pharmaceutica&rft.au=Arora,%20Saahil&rft.date=2011-07&rft.volume=79&rft.issue=3&rft.spage=673&rft.epage=694&rft.pages=673-694&rft.issn=0036-8709&rft.eissn=2218-0532&rft_id=info:doi/10.3797/scipharm.1011-05&rft_dat=%3Cproquest_pubme%3E2439647311%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3375-b1518f04023f8f5e825a88fe2527ec67043dcc1a14d95f4a18038c313d6d3a5d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=886556319&rft_id=info:pmid/21886911&rfr_iscdi=true |